Registry-listed formulations

resorcinol · mesh:C031389

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • ResorcinolRegistry product

    Linked study entry; product equivalence not established

    Formulation reported by source: CREAM

    View study and source

Success Metrics

Active Trials
0(0%)

Phase Distribution

Phase 4
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

not_yet_recruiting1100%

Recent Activity

0 active trials
Showing 1 of 1
not_yet_recruitingphase_4

Adalimumab Treatment for Patients with Hidradenitis Suppurativa at high risk of Severe Disease

SYFf04fe00c0e79462a96d91a5cf23e76fd

Clinical Trials (1)

Showing 1 of 1 trials
SYFf04fe00c0e79462a96d91a5cf23e76fdPhase 4

Adalimumab Treatment for Patients with Hidradenitis Suppurativa at high risk of Severe Disease

Not Yet Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Type not reported
Total Trials
1

Names & Codes

Trade Names

r a acne